4/A//SEC Filing
UPPALURI SUBBARAO V 4/A
Accession 0001209191-10-015893
CIK 0001302554other
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 2:26 PM ET
Size
7.8 KB
Accession
0001209191-10-015893
Insider Transaction Report
Form 4/AAmended
UPPALURI SUBBARAO V
Director
Transactions
- Conversion
Series A Convertible Preferred Stock
2009-09-24−127→ 0 totalExercise: $0.00→ Common Stock (127,000 underlying)
Footnotes (3)
- [F1]This Form 4 is being filed to amend a line of transaction information appearing on a previously-filed Form 4, which was previously filed on September 28, 2009, in which (i) column 5 of Table II inadvertently and erroneously indicated that Mr. Uppaluri had disposed of 229 shares of Series A Convertible Preferred Stock and (ii) column 7 of Table II inadvertently and erroneously indicated 229,000 shares of Common Stock (as defined below) underlying such Series A Convertible Preferred Stock. This Form 4 amends such line of transaction information as follows: (i) column 5 of Table II has been amended to indicate that Mr. Uppaluri disposed of 127 shares of Series A Convertible Preferred Stock; and (ii) column 7 of Table II has been amended to indicate 127,000 shares of Common Stock (as defined below) underlying such Series A Convertible Preferred Stock.
- [F2]Effective September 24, 2009, each outstanding share of Winston Pharmaceuticals, Inc. (the "Company") Series A Convertible Preferred Stock, par value $0.001 per share ("Series A Preferred Stock"), automatically converted into 1,000 shares of the Company's common stock, par value $0.001 per share ("Common Stock").
- [F3]Reported amounts reflect share ownership subsequent to the effectuation by the Company on December 15, 2008 (the "Reverse Split Date") of a 1-for-8 reverse stock split whereby each eight shares of the Company's common stock and preferred stock either issued and outstanding or held as treasury shares immediately prior to the Reverse Split Date were automatically reduced and continued as one share of the Company's common stock or preferred stock, as applicable. All of the Company's outstanding securities were adjusted accordingly to reflect such reverse split.
Documents
Issuer
Winston Pharmaceuticals, Inc.
CIK 0001302554
Entity typeother
Related Parties
1- filerCIK 0001389406
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 9, 7:00 PM ET
- Accepted
- Mar 10, 2:26 PM ET
- Size
- 7.8 KB